Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women

European Journal of Cancer

Volumn 36, Issue 18, 2000, Pages 2313-2316

  Gershoni Baruch, R ^a,b   Dagan, E ^a   Israeli, D ^c   Kasinetz, L ^a   Kadouri, E ^a   Friedman, E ^c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

Bilateral breast cancer; BRCA1; BRCA2; Breast ovarian cancer; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; JEW; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HOMOZYGOTE; HUMANS; JEWS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0033695123     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00306-3     Document Type: Article

References (15)

1. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
2. Analysis of the 677 C → T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups
3. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations
4. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase
5. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer
6. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer
7. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility
8. Loss of heterozygosity at the 5' 10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas
9. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families
10. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
11. High frequency of the 185delAG mutation in ovarian cancer in Israel
12. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
13. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
14. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 605 of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women
15. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis